| Market Cap | ₹82Cr |
| ROE | 1.67% |
| P/E Ratio(TTM) | 141.93 |
| EPS(TTM) | 0.58 |
| P/B Ratio | 2.39 |
| Dividend Yield | 0.00% |
| Industry P/E | 33.18 |
| Book Value | 34.42 |
| Debt to Equity | 0.50 |
| Face Value | 10 |
| Parent Organisation | Concord Drugs Limited |
| Managing Director | Mr. S. Nagi Reddy |
| Founded | 1995 |
| BSE Symbol | 538965 |
| COMPANY | 52 WEEK | MARKET PRICE | P/E Ratio | |
|---|---|---|---|---|
| JB Chemicals & Pharmaceuticals | NA (0.00%) | 38.94 | ||
| Emcure Pharmaceuticals | NA (0.00%) | 32.07 | ||
| Wockhardt | NA (0.00%) | -439.39 | ||
| Cohance Lifesciences | NA (0.00%) | 64.75 |